Oramed Pharmaceuticals’ CEO Letter to Shareholders

JERUSALEM, Jan. 15, 2019 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com) Dear Shareholders, We opened the year 2019 with the announcement of our receipt of a $3 million milestone payment from our partners HTIT, thereby increasing our total payments from HTIT received to date to $33 million. We had a busy year […]